Recognize Vital Features for Classification of Neurodegenerative Diseases

2019 ◽  
pp. 287-301 ◽  
Author(s):  
A. Athisakthi ◽  
M. Pushpa Rani
Keyword(s):  
Neurodegenerative Diseases

Rule based classification of neurodegenerative diseases using data driven gait features

2018 ◽  
Vol 9 (4) ◽  
pp. 547-560 ◽  
Author(s):  
Kartikay Gupta ◽  
Aayushi Khajuria ◽  
Niladri Chatterjee ◽  
Pradeep Joshi ◽  
Deepak Joshi
Keyword(s):  
Neurodegenerative Diseases ◽  
Data Driven ◽  
Rule Based ◽  
Gait Features ◽  
Using Data

scholarly journals Classification of Neurodegenerative Diseases via Topological Motion Analysis—A Comparison Study for Multiple Gait Fluctuations

IEEE Access ◽  
2020 ◽  
Vol 8 ◽  
pp. 96363-96377 ◽  
Author(s):  
Yan Yan ◽  
Olatunji Mumini Omisore ◽  
Yu-Cheng Xue ◽  
Hui-Hui Li ◽  
Qiu-Hua Liu ◽  
...  
Keyword(s):  
Neurodegenerative Diseases ◽  
Motion Analysis ◽  
Comparison Study

scholarly journals Kynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients

Biomolecules ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. 571 ◽  
Author(s):  
Marta González-Sánchez ◽  
Javier Jiménez ◽  
Arantzazu Narváez ◽  
Desiree Antequera ◽  
Sara Llamas-Velasco ◽  
...  
Keyword(s):  
Neurodegenerative Diseases ◽  
Neurodegenerative Disorders ◽  
Healthy Subjects ◽  
Kynurenic Acid ◽  
Kynurenine Pathway ◽  
Healthy Controls ◽  
Specific Increase ◽  
Normal Controls ◽  
Lateral Sclerosis

Kynurenic acid (KYNA) is a product of the tryptophan (TRP) metabolism via the kynurenine pathway (KP). This pathway is activated in neurodegenerative disorders, such as Alzheimer´s disease (AD). KYNA is primarily produced by astrocytes and is considered neuroprotective. Thus, altered KYNA levels may suggest an inflammatory response. Very recently, significant increases in KYNA levels were reported in cerebrospinal fluid (CSF) from AD patients compared with normal controls. In this study, we assessed the accuracy of KYNA in CSF for the classification of patients with AD, cognitively healthy controls, and patients with a variety of other neurodegenerative diseases, including frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and progressive supranuclear palsy (PSP). Averaged KYNA concentration in CSF was higher in patients with AD when compared with healthy subjects and with all the other differentially diagnosed groups. There were no significant differences in KYNA levels in CSF between any other neurodegenerative groups and controls. These results suggest a specific increase in KYNA concentration in CSF from AD patients not seen in other neurodegenerative diseases.

Extracting Salient Brain Patterns for Imaging-Based Classification of Neurodegenerative Diseases

2014 ◽  
Vol 33 (6) ◽  
pp. 1262-1274 ◽  
Author(s):  
Andrea Rueda ◽  
Fabio A. Gonzalez ◽  
Eduardo Romero
Keyword(s):  
Neurodegenerative Diseases
Sign in / Sign up

Export Citation Format

Share Document